Some of the most powerful medicines we will ever find are already here, carried in the fangs, stingers, and saliva of ...

This is the year artificial intelligence has emerged in the public square as a full-fledged bogeyman. So this month’s low-key ...

Glenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens ...

Erica Schwartz and Sean Kaufman navigated tough questions about vaccines, political independence, and pushing back on RFK Jr.

An Alzheimer’s drug from Biogen slowed cognitive decline in a mid-stage trial at roughly comparable rates as approved ...

A new study claims to have uncovered how Epstein-Barr virus launches immune responses seen in people with multiple sclerosis.

When the body’s most important blood vessel tears from the inside, it’s a medical emergency that can be years in the making.

Medicare regulators on Tuesday proposed to ban vendors from providing remote patient monitoring services on behalf of doctors ...

A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has ...

Managing risk factors is the key to further progress in reducing deaths from coronary artery disease, a new study finds.

Elevance Health, the country’s second-biggest health insurer, said it plans to further shrink its Medicaid portfolio in the ...

You cannot thin a system, defer the tools that would speed it up, and then wonder why the public is left guessing,” writes ...